학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 248건 | 목록 1~10
Academic Journal
Belmontes B; Amgen Inc., Thousand Oaks, CA, United States.; Slemmons KK; Amgen Inc., Thousand Oaks, CA, United States.; Su C; Amgen (United States), South San Francisco, CA, United States.; Liu S; Amgen Inc., Thousand Oaks, CA, United States.; Policheni AN; Walter and Eliza Hall Institute of Medical Research, Australia.; Moriguchi J; Amgen Inc., Thousand Oaks, CA, United States.; Tan H; Amgen Inc., Thousand Oaks, CA, United States.; Xie F; Amgen (United States), South San Francisco, CA, United States.; Aiello DA; Amgen Inc., Thousand Oaks, CA, United States.; Yang Y; Amgen Inc., Thousand Oaks, CA, United States.; Lazaro R; Amgen (United States), Thousand Oaks, CA, United States.; Aeffner F; Amgen (United States), South San Francisco, CA, United States.; Rees MG; Broad Institute, Cambridge, MA, United States.; Ronan MM; Broad Institute, Cambridge, MA, United States.; Roth JA; Broad Institute, Cambridge, MA, United States.; Vestergaard M; Amgen Inc., Copenhagen, Denmark.; Cowland S; Amgen Inc., Copenhagen, Denmark.; Andersson J; Amgen Inc., Copenhagen, Denmark.; Sarvary I; Amgen Inc., Copenhagen, Denmark.; Chen Q; Amgen Inc., Thousand Oaks, CA, United States.; Sharma P; Amgen Inc., Thousand Oaks, CA, United States.; Lopez P; Amgen Inc., Thousand Oaks, CA, United States.; Tamayo N; Amgen Inc., Thousand Oaks, CA, United States.; Pettus LH; Amgen Inc., Thousand Oaks, CA, United States.; Ghimire-Rijal S; Amgen Inc., Thousand Oaks, CA, United States.; Mukund S; Amgen Inc., Thousand Oaks, CA, United States.; Allen JR; Amgen Inc., Thousand Oaks, CA, United States.; DeVoss J; Amgen (United States), South San Francisco, CA, United States.; Coxon A; Amgen Inc., Thousand Oaks, CA, United States.; Rodon J; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.; Ghiringhelli F; Centre Georges François Leclerc, Dijon, France.; Penel N; Centre Oscar Lambret, Lille, France.; Prenen H; University Hospital Antwerp, Edegem, Belgium.; Glad S; Amgen Inc., Copenhagen, Denmark.; Chuang CH; Amgen (United States), South San Francisco, CA, United States.; Keyvanjah K; Amgen Inc, Thousand Oaks, CA, United States.; Townsley DM; AstraZeneca, Gaithersburg, Maryland, United States.; Butler JR; Amgen Inc., Thousand Oaks, CA, United States.; Bourbeau MP; Pfizer (United States), La Jolla, CA, United States.; Caenepeel S; Amgen Inc., Thousand Oaks, CA, United States.; Hughes PE; Amgen Inc., Thousand Oaks, CA, United States.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE
Academic Journal
Majd NK; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Vo HH; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Moran CA; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.; Weathers SP; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Song IW; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Williford GL; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Rodon J; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Fu S; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Tsimberidou AM; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE
Academic Journal
Rodon J; MD Anderson Cancer Center, Houston, TX, USA. Electronic address: jrodon@mdanderson.org.; Prenen H; University Hospital Antwerp, Edegem, Belgium.; Sacher A; Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.; Villalona-Calero M; University of California, Irvine, CA, USA.; Penel N; Centre Oscar Lambret, Lille, France.; El Helali A; Centre of Cancer Medicine, University of Hong Kong, Hong Kong, China.; Rottey S; Ghent University Hospital, Ghent, Belgium.; Yamamoto N; National Cancer Center Hospital, Tokyo, Japan.; Ghiringhelli F; INSERM U866, Cancer Center Georges Francois Leclerc, Dijon, France.; Goebeler ME; Comprehensive Cancer Center Mainfranken, University Hospital Würzburg.; Doi T; National Cancer Center Hospital East, Chiba, Japan.; Postel-Vinay S; Institut Gustave Roussy, Villejuif, France and University College London Cancer Institute, London, UK.; Lin CC; National Taiwan University Hospital, Taipei, Taiwan.; Liu C; Amgen Inc., Thousand Oaks, CA, USA.; Chuang CH; Amgen Inc., Thousand Oaks, CA, USA.; Keyvanjah K; Amgen Inc., Thousand Oaks, CA, USA.; Eggert T; Amgen Inc., Thousand Oaks, CA, USA.; O'Neil BH; Community-Health Network, Indianapolis, IN, USA.
Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Academic Journal
Westphalen CB; Comprehensive Cancer Center Munich & Department of Medicine III, University Hospital, LMU Munich, Munich; German Cancer Consortium (DKTK), partner site Munich, German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address: education@esmo.org.; Martins-Branco D; Scientific and Medical Division, European Society for Medical Oncology (ESMO), Lugano, Switzerland.; Beal JR; Hospital Israelita Albert Einstein, Sao Paulo, Brazil.; Cardone C; Experimental Clinical Abdominal Oncology Unit, Istituto Nazionale Tumori- IRCCS-Fondazione G. Pascale, Naples, Italy.; Coleman N; School of Medicine, Trinity College Dublin, Dublin; Medical Oncology Department, St. James's Hospital, Dublin; Trinity St. James's Cancer Institute, Dublin, Ireland.; Schram AM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City; Weill Cornell Medical College, New York City.; Halabi S; Department of Biostatistics and Bioinformatics, Duke University, Durham; Duke Cancer Institute, Duke University, Durham, USA.; Michiels S; Oncostat U1018, Inserm, Université Paris-Saclay, labeled Ligue Contre le Cancer, Villejuif; Service de Biostatistique et Epidémiologie, Gustave Roussy, Villejuif, France.; Yap C; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK.; André F; INSERM U981, Gustave Roussy, Villejuif; Department of Cancer Medicine, Gustave Roussy, Villejuif; Faculty of Medicine, Université Paris-Saclay, Kremlin Bicêtre.; Bibeau F; Service d'Anatomie Pathologique, CHU Besançon, Université de Bourgogne Franche-Comté, Besançon, France.; Curigliano G; Istituto Europeo di Oncologia, IRCCS, Milan; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy.; Garralda E; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Kummar S; Division of Hematology and Medical Oncology, Department of Medicine, Knight Cancer Institute, Oregon Health and Science University, Portland.; Kurzrock R; Department of Medicine, Medical College of Wisconsin Cancer Center, Milwaukee, USA.; Limaye S; Medical & Precision Oncology, Sir H. N. Reliance Foundation Hospital & Research Centre, Mumbai, India.; Loges S; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, Department of Personalized Oncology, University Hospital Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim; Division of Personalized Medical Oncology (A420), German Cancer Research Center (DKFZ), German Center for Lung Research (DZL), German Cancer Consortium (DKTK), Heidelberg, Germany.; Marabelle A; Drug Development Department (DITEP) and Laboratory for Translational Research in Immunotherapy (LRTI), Gustave Roussy, INSERM U1015 & CIC1428, Université Paris-Saclay, Villejuif, France.; Marchió C; Department of Medical Sciences, University of Turin, Turin; Division of Pathology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.; Mateo J; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Rodon J; Department of Investigational Cancer Therapeutics, UT MD Anderson, Houston, USA.; Spanic T; Europa Donna Slovenia, Ljubljana, Slovenia.; Pentheroudakis G; Scientific and Medical Division, European Society for Medical Oncology (ESMO), Lugano, Switzerland.; Subbiah V; Early-Phase Drug Development, Sarah Cannon Research Institute (SCRI), Nashville, USA.
Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Academic Journal
Silva DJ; Local Health Unity of Matosinhos - Hospital Pedro Hispano, Matosinhos, Portugal.; Nelson BE; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Rodon J; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publisher: Innovative Healthcare Institute Country of Publication: United States NLM ID: 101768397 Publication Model: eCollection Cited Medium: Internet ISSN: 2590-017X (Electronic) Linking ISSN: 2590017X NLM ISO Abbreviation: J Immunother Precis Oncol Subsets: PubMed not MEDLINE
Rodón J; The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jrodon@mdanderson.org.; Damian S; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Furqan M; University of Iowa, Iowa City, IA, USA.; García-Donas J; Centro Integral Oncologico Clara Campal, Madrid, Spain.; Imai H; Tohoku University Hospital, Sendai-Shi, Japan.; Italiano A; Institut Bergonié, Bordeaux, France.; Faculty of Medicine, University of Bordeaux, Bordeaux, France.; Spanggaard I; Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark.; Ueno M; Kanagawa Cancer Center, Yokohama, Japan.; Yokota T; Shizuoka Cancer Center, Shizuoka, Japan.; Veronese ML; Incyte International Biosciences Sàrl, Morges, Switzerland.; Oliveira N; Incyte International Biosciences Sàrl, Morges, Switzerland.; Li X; Incyte Corporation, Wilmington, DE, USA.; Gilmartin A; Incyte Corporation, Wilmington, DE, USA.; Schaffer M; Incyte Corporation, Wilmington, DE, USA.; Goyal L; Mass General Cancer Center, Harvard Medical School, Boston, MA, USA. lgoyal@stanford.edu.; Stanford Cancer Center, Stanford School of Medicine, Stanford, CA, USA. lgoyal@stanford.edu.
Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: PubMed not MEDLINE; MEDLINE
Academic Journal
Piha-Paul SA; Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), University of Texas MD Anderson Cancer Center, Houston, TX, USA. spihapau@mdanderson.org.; Tseng C; Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Leung CH; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Yuan Y; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Karp DD; Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Subbiah V; Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hong D; Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Fu S; Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Naing A; Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Rodon J; Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Javle M; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ajani JA; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Raghav KP; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Somaiah N; Department of Sarcoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Mills GB; Knight Cancer Institute, Oregon Health Sciences University, Portland, OR, USA.; Tsimberidou AM; Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Zheng X; Department of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Chen K; Department of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Meric-Bernstam F; Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; The Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE
Leary A; Medical Oncology, Institut Gustave Roussy, Villejuif, France.; Estévez-García P; Medical Oncology, Hospital Universitario Virgen del Rocío, Sevilla, Spain.; Sabatier R; Department of Medical Oncology, Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes, 232 Boulevard Sainte Marguerite, Marseille, France.; Ray-Coquard I; Medical Oncology, Centre Léon Bérard, Lyon, France.; Romeo M; Department of Medical Oncology, Department of Medicine, Institut Català d'Oncologia Badalona Hospital Germans Trias i Pujol, Badalona-Applied Research Group in Oncology, Germans Trias i Pujol Institute, Universitat Autònoma de Barcelona, Badalona, Spain.; Barretina-Ginesta P; Medical Oncology Department, Precision Oncology Group (OncoGIR-Pro) Girona Biomedical Research Institute (IDIBGI) and Department of Medical Sciences, Institut Català d'Oncologia (ICO), Medical School University of Girona (UdG), Girona, Spain.; Gil-Martin M; Medical Oncology, Catalan Institute of Oncology and IDIBELL, L'Hospitalet del Llobregat, Barcelona, Spain.; Garralda E; Medical Oncology Service, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Bosch-Barrera J; Medical Oncology Department, Precision Oncology Group (OncoGIR-Pro) Girona Biomedical Research Institute (IDIBGI) and Department of Medical Sciences, Institut Català d'Oncologia (ICO), Medical School University of Girona (UdG), Girona, Spain.; Morán T; Department of Medical Oncology, Department of Medicine, Institut Català d'Oncologia Badalona Hospital Germans Trias i Pujol, Badalona-Applied Research Group in Oncology, Germans Trias i Pujol Institute, Universitat Autònoma de Barcelona, Badalona, Spain.; Martin-Martorell P; Medical Oncology, INCLIVA-Hospital Clínico Universitario, Valencia, Spain.; Nadal E; Medical Oncology, Catalan Institute of Oncology and IDIBELL, L'Hospitalet del Llobregat, Barcelona, Spain.; Gascón P; Medical Oncology Service, Hospital Clínic. Universitat de Barcelona, Barcelona, Spain.; Rodon J; Early Drug Development, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.; Lizcano JM; Department of Biochemistry and Molecular Biology, Institut de Neurocièncias, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Barcelona, Spain.; Protein Kinases in Cancer Research, Vall Hebron Institut de Recerca (VHIR), Barcelona, Spain.; Muñoz-Guardiola P; Department of Biochemistry and Molecular Biology, Institut de Neurocièncias, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Barcelona, Spain.; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain.; Fierro-Durán G; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain.; Pedrós-Gámez O; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain.; Pérez-Montoyo H; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain.; Yeste-Velasco M; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain.; Cortal M; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain.; Pérez-Campos A; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain.; Alfon J; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain.; Domenech C; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain. carles.domenech@abilitypharma.com.; Pérez-Fidalgo A; Medical Oncology, INCLIVA-Hospital Clínico Universitario, Valencia, Spain.; Oaknin A; Medical Oncology Service, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: PubMed not MEDLINE; MEDLINE
Academic Journal
Garcia-Sanchez P; Pediatric Emergency Department, La Paz University Hospital, Madrid, Spain.; Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.; Doctoral Program in Medicine and Surgery, Autonomous University of Madrid, Madrid, Spain.; Romero-Trancón D; Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.; Falces-Romero I; Clinical Microbiology Department, La Paz University Hospital, Madrid, Spain.; Center for Biomedical Research in Infectious Diseases Network (CIBERINFEC), Carlos III Health Institute, Madrid, Spain.; Navarro Carrera P; Clinical Microbiology Department, La Paz University Hospital, Madrid, Spain.; Ruiz-Carrascoso G; Clinical Microbiology Department, La Paz University Hospital, Madrid, Spain.; Center for Biomedical Research in Infectious Diseases Network (CIBERINFEC), Carlos III Health Institute, Madrid, Spain.; Carmena D; Center for Biomedical Research in Infectious Diseases Network (CIBERINFEC), Carlos III Health Institute, Madrid, Spain.; Parasitology Reference and Research Laboratory, National Center of Microbiology, Carlos III Health Institute, Majadahonda, Spain.; Casares Jiménez M; Center for Biomedical Research in Infectious Diseases Network (CIBERINFEC), Carlos III Health Institute, Madrid, Spain.; Infectious Diseases Unit, Reina Sofía University Hospital, Maimónides Biomedical Research Institute of Córdoba, University of Córdoba, Córdoba, Spain.; Rivero-Juárez A; Center for Biomedical Research in Infectious Diseases Network (CIBERINFEC), Carlos III Health Institute, Madrid, Spain.; Infectious Diseases Unit, Reina Sofía University Hospital, Maimónides Biomedical Research Institute of Córdoba, University of Córdoba, Córdoba, Spain.; Moya L; Idexx Laboratories, Barcelona, Spain.; Rodón J; Idexx Laboratories, Barcelona, Spain.; Esperón F; Veterinary Faculty, European University of Madrid, Villaviciosa de Odón, Madrid, Spain.; Pérez-Hernando B; Center for Biomedical Research in Infectious Diseases Network (CIBERINFEC), Carlos III Health Institute, Madrid, Spain.; Sánchez-León R; Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.; Doctoral Program in Microbiology, Autonomous University of Madrid, Madrid, Spain.; Hurtado-Gallego J; Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.; Center for Biomedical Research in Infectious Diseases Network (CIBERINFEC), Carlos III Health Institute, Madrid, Spain.; Alcolea S; Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.; Doctoral Program in Medicine and Surgery, Autonomous University of Madrid, Madrid, Spain.; Center for Biomedical Research in Infectious Diseases Network (CIBERINFEC), Carlos III Health Institute, Madrid, Spain.; Pediatric Infectious and Tropical Diseases Department, La Paz University Hospital, Madrid, Spain.; Pediatrics Department, Severo Ochoa Leganés University Hospital, Madrid, Spain.; Puerta de Hierro Health Research Institute (IDIPHISA), Majadahonda, Spain.; Sainz T; Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.; Center for Biomedical Research in Infectious Diseases Network (CIBERINFEC), Carlos III Health Institute, Madrid, Spain.; Pediatric Infectious and Tropical Diseases Department, La Paz University Hospital, Madrid, Spain.; Pediatric Department, Autonomous University of Madrid, Madrid, Spain.; Translational Research Network in Pediatric Infectious Diseases, Madrid, Spain.; Calvo C; Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.; Center for Biomedical Research in Infectious Diseases Network (CIBERINFEC), Carlos III Health Institute, Madrid, Spain.; Pediatric Infectious and Tropical Diseases Department, La Paz University Hospital, Madrid, Spain.; Pediatric Department, Autonomous University of Madrid, Madrid, Spain.; Translational Research Network in Pediatric Infectious Diseases, Madrid, Spain.; Méndez-Echevarría A; Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.; Center for Biomedical Research in Infectious Diseases Network (CIBERINFEC), Carlos III Health Institute, Madrid, Spain.; Pediatric Infectious and Tropical Diseases Department, La Paz University Hospital, Madrid, Spain.; Pediatric Department, Autonomous University of Madrid, Madrid, Spain.; Translational Research Network in Pediatric Infectious Diseases, Madrid, Spain.; ERN TransplantChild, Madrid, Spain.
Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101666658 Publication Model: eCollection Cited Medium: Print ISSN: 2297-1769 (Print) Linking ISSN: 22971769 NLM ISO Abbreviation: Front Vet Sci Subsets: PubMed not MEDLINE
Academic Journal
Leary A; Medical Oncology, Institut Gustave Roussy, Villejuif, France.; Estévez-García P; Medical Oncology, Hospital Universitario Virgen del Rocío, Sevilla, Spain.; Sabatier R; Department of Medical Oncology, Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes, 232 Boulevard Sainte Marguerite, Marseille, France.; Ray-Coquard I; Medical Oncology, Centre Léon Bérard, Lyon, France.; Romeo M; Department of Medical Oncology, Department of Medicine, Institut Català d'Oncologia Badalona Hospital Germans Trias i Pujol, Badalona-Applied Research Group in Oncology, Germans Trias i Pujol Institute, Universitat Autònoma de Barcelona, Badalona, Spain.; Barretina-Ginesta P; Medical Oncology Department, Precision Oncology Group (OncoGIR-Pro) Girona Biomedical Research Institute (IDIBGI) and Department of Medical Sciences, Institut Català d'Oncologia (ICO), Medical School University of Girona (UdG), Girona, Spain.; Gil-Martin M; Medical Oncology, Catalan Institute of Oncology and IDIBELL, L'Hospitalet del Llobregat, Barcelona, Spain.; Garralda E; Medical Oncology Service, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Bosch-Barrera J; Medical Oncology Department, Precision Oncology Group (OncoGIR-Pro) Girona Biomedical Research Institute (IDIBGI) and Department of Medical Sciences, Institut Català d'Oncologia (ICO), Medical School University of Girona (UdG), Girona, Spain.; Morán T; Department of Medical Oncology, Department of Medicine, Institut Català d'Oncologia Badalona Hospital Germans Trias i Pujol, Badalona-Applied Research Group in Oncology, Germans Trias i Pujol Institute, Universitat Autònoma de Barcelona, Badalona, Spain.; Martin-Martorell P; Medical Oncology, INCLIVA-Hospital Clínico Universitario, Valencia, Spain.; Nadal E; Medical Oncology, Catalan Institute of Oncology and IDIBELL, L'Hospitalet del Llobregat, Barcelona, Spain.; Gascón P; Medical Oncology Service, Hospital Clínic. Universitat de Barcelona, Barcelona, Spain.; Rodon J; Early Drug Development, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.; Lizcano JM; Department of Biochemistry and Molecular Biology, Institut de Neurocièncias, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Barcelona, Spain.; Protein Kinases in Cancer Research, Vall Hebron Institut de Recerca (VHIR), Barcelona, Spain.; Muñoz-Guardiola P; Department of Biochemistry and Molecular Biology, Institut de Neurocièncias, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Barcelona, Spain.; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain.; Fierro-Durán G; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain.; Pedrós-Gámez O; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain.; Pérez-Montoyo H; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain.; Yeste-Velasco M; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain.; Cortal M; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain.; Pérez-Campos A; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain.; Alfon J; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain.; Domenech C; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain. carles.domenech@abilitypharma.com.; Pérez-Fidalgo A; Medical Oncology, INCLIVA-Hospital Clínico Universitario, Valencia, Spain.; Oaknin A; Medical Oncology Service, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Rodon J
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어